| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alto Neuroscience, Inc. | Director | Employee Stock Option (right to buy) | 4,228 | $49,974 | $11.82 | 02 Jan 2026 | Direct |
| Alto Neuroscience, Inc. | Director | Stock Option (right to buy) | 15,287 | $44,998 | $3.17 | 13 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | 02 Jan 2026 | 1 | +$49,975 | 4 | Director | 06 Jan 2026, 16:46 |
| ANRO | Alto Neuroscience, Inc. | 13 May 2025 | 1 | $0 | 4 | Director | 15 May 2025, 16:16 |
| ANRO | Alto Neuroscience, Inc. | 02 Jan 2025 | 1 | +$44,998 | 4 | Director | 06 Jan 2025, 16:17 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2024 | 2 | +$36,638 | 4 | Director | 05 Feb 2024, 16:45 |
| ANRO | Alto Neuroscience, Inc. | 01 Feb 2024 | 0 | $0 | 3 | Director | 01 Feb 2024, 18:55 |